المؤلفون: Dang J; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150000, Heilongjiang, China., Xu G; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150000, Heilongjiang, China., Guo G; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150000, Heilongjiang, China., Zhang H; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150000, Heilongjiang, China., Shang L; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150000, Heilongjiang, China. shanglhsmile@163.com.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 May 15; Vol. 150 (5), pp. 255. Date of Electronic Publication: 2024 May 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality , Lung Neoplasms*/therapy , Lung Neoplasms*/immunology , Small Cell Lung Carcinoma*/drug therapy , Small Cell Lung Carcinoma*/pathology , Small Cell Lung Carcinoma*/therapy , Small Cell Lung Carcinoma*/mortality , Small Cell Lung Carcinoma*/immunology, Humans ; Male ; Female ; Retrospective Studies ; Prognosis ; Middle Aged ; China/epidemiology ; Aged ; Immune Checkpoint Inhibitors/therapeutic use ; Immunotherapy/methods ; Nomograms ; Adult ; Neoplasm Staging ; Treatment Outcome

المؤلفون: Yeghaian M; GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.; Radiology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., Tareco Bucho TM; GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.; Radiology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Bruin M; Radiology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., Schmitz A; Radiology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., Bodalal Z; GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.; Radiology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., Smit EF; Pulmonology Department, Leiden University Medical Center, Leiden, The Netherlands., Beets-Tan RGH; GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.; Radiology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark., van den Broek D; Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands., Trebeschi S; GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands. stefano.trebeschi@maastrichtuniversity.nl.; Radiology Department, Netherlands Cancer Institute, Amsterdam, The Netherlands. stefano.trebeschi@maastrichtuniversity.nl.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Jun 26; Vol. 150 (6), pp. 329. Date of Electronic Publication: 2024 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/blood , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/therapy , Carcinoma, Non-Small-Cell Lung*/mortality , Lung Neoplasms*/blood , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/therapy , Lung Neoplasms*/mortality , Biomarkers, Tumor*/blood , Immune Checkpoint Inhibitors*/therapeutic use , Disease Progression* , Immunotherapy*/methods , Response Evaluation Criteria in Solid Tumors*, Humans ; Male ; Retrospective Studies ; Female ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Prognosis

المؤلفون: Li X; Department of Thoracic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Wu; The Centre of Molecular Diagnosis, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Tang J; Department of Lymphoma, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Wu Y; Department of Lymphoma, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. wuyuebing0328@126.com.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 May 23; Vol. 150 (5), pp. 271. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Temozolomide*/therapeutic use , Temozolomide*/administration & dosage , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Brain Neoplasms*/secondary , Brain Neoplasms*/drug therapy , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/administration & dosage, Humans ; Retrospective Studies ; Male ; Middle Aged ; Female ; Aged ; Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; B7-H1 Antigen/antagonists & inhibitors

المؤلفون: Tamura K; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo, Tokyo, 104-0045, Japan.; Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato, Tokyo, 105-8461, Japan., Okuma Y; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo, Tokyo, 104-0045, Japan. yokuma@ncc.go.jp., Nomura S; Department of Biostatics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo, Tokyo, 113-8655, Japan., Fukuda A; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo, Tokyo, 104-0045, Japan., Masuda K; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo, Tokyo, 104-0045, Japan., Matsumoto Y; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo, Tokyo, 104-0045, Japan., Shinno Y; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo, Tokyo, 104-0045, Japan., Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo, Tokyo, 104-0045, Japan.; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo, Tokyo, 104-0045, Japan., Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo, Tokyo, 104-0045, Japan., Horinouchi H; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo, Tokyo, 104-0045, Japan., Yamamoto N; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo, Tokyo, 104-0045, Japan.; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo, Tokyo, 104-0045, Japan., Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo, Tokyo, 104-0045, Japan.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Apr 26; Vol. 150 (4), pp. 216. Date of Electronic Publication: 2024 Apr 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Dysbiosis*/chemically induced , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Anti-Bacterial Agents*/adverse effects , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/administration & dosage , Propensity Score* , Immunotherapy*/adverse effects , Immunotherapy*/methods, Humans ; Female ; Male ; Middle Aged ; Retrospective Studies ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Adult ; Gastrointestinal Microbiome/drug effects

المؤلفون: Wang Y; Department of Radiology, Second Affiliated Hospital of Navy Medical University, 415 Fengyang Road, Huangpu District, Shanghai, 200003, China., Lyu D; Department of Radiology, Second Affiliated Hospital of Navy Medical University, 415 Fengyang Road, Huangpu District, Shanghai, 200003, China., Cheng C; Department of Nuclear Medicine, Changhai Hospital, Navy Medical University, Shanghai, 200433, China., Zhou T; Department of Radiology, Second Affiliated Hospital of Navy Medical University, 415 Fengyang Road, Huangpu District, Shanghai, 200003, China., Tu W; Department of Radiology, Second Affiliated Hospital of Navy Medical University, 415 Fengyang Road, Huangpu District, Shanghai, 200003, China., Xiao Y; Department of Radiology, Second Affiliated Hospital of Navy Medical University, 415 Fengyang Road, Huangpu District, Shanghai, 200003, China., Zuo C; Department of Nuclear Medicine, Changhai Hospital, Navy Medical University, Shanghai, 200433, China. Zuo@qq.com., Fan L; Department of Radiology, Second Affiliated Hospital of Navy Medical University, 415 Fengyang Road, Huangpu District, Shanghai, 200003, China. fanli0930@163.com., Liu S; Department of Radiology, Second Affiliated Hospital of Navy Medical University, 415 Fengyang Road, Huangpu District, Shanghai, 200003, China. radiology_cz@163.com.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Apr 10; Vol. 150 (4), pp. 185. Date of Electronic Publication: 2024 Apr 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/diagnostic imaging , Carcinoma, Non-Small-Cell Lung*/surgery , Lung Neoplasms*/diagnostic imaging , Lung Neoplasms*/surgery, Humans ; Fluorodeoxyglucose F18 ; Positron Emission Tomography Computed Tomography ; Nomograms ; Retrospective Studies

المؤلفون: Zhao R; Cancer Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, Jilin, China., Guan X; Cancer Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, Jilin, China., Zhang P; Thoracic Surgery Department, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, Jilin, China., Liu Y; Thoracic Surgery Department, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, Jilin, China., Xu Y; Cancer Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, Jilin, China., Sun C; Cancer Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, Jilin, China., Qiu S; Cancer Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, Jilin, China., Zhu W; Cancer Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, Jilin, China., Yang Z; Thoracic Surgery Department, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, Jilin, China. zgyang@jlu.edu.cn., Wang X; Cancer Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, Jilin, China. 365658791@163.com.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Apr 04; Vol. 150 (4), pp. 175. Date of Electronic Publication: 2024 Apr 04.

نوع المنشور: Case Reports; Journal Article; Review

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/surgery , Lung Neoplasms*/drug therapy , Lung Neoplasms*/surgery , Fistula*, Humans ; Neoadjuvant Therapy/adverse effects ; Immune Checkpoint Inhibitors ; Immunotherapy/adverse effects ; Postoperative Complications/etiology

المؤلفون: Niu L; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China., Wu H; Department of Oncology, Xiangxi Autonomous Prefecture People's Hospital, Jishou, 416000, China., Gao R; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China., Chen L; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China., Wang J; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China., Duan H; Department of Oncology, Xiangxi Autonomous Prefecture People's Hospital, Jishou, 416000, China., Long Y; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China., Xie Y; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China., Zhou Q; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China. zhouqin5796@csu.edu.cn., Zhou R; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China. zhourr@csu.edu.cn.; Xiangya Lung Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China. zhourr@csu.edu.cn.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China. zhourr@csu.edu.cn.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Feb 19; Vol. 150 (2), pp. 94. Date of Electronic Publication: 2024 Feb 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Tyrosine Kinase Inhibitors*/therapeutic use, Humans ; ErbB Receptors/genetics ; Mutation ; Prospective Studies ; Retrospective Studies

المؤلفون: Wang Y; Clinical Laboratory, The First Affiliated Hospital of Weifang Medical University (Weifang People's Hospital), Weifang Medical University, Weifang, 261000, Shandong, China.; Department of Clinical Laboratory Science, Weifang Medical University, Weifang, 261000, Shandong, China., Dong A; Clinical Laboratory, The First Affiliated Hospital of Weifang Medical University (Weifang People's Hospital), Weifang Medical University, Weifang, 261000, Shandong, China., Jin M; Clinical Laboratory, The First Affiliated Hospital of Weifang Medical University (Weifang People's Hospital), Weifang Medical University, Weifang, 261000, Shandong, China.; Department of Clinical Laboratory Science, Weifang Medical University, Weifang, 261000, Shandong, China., Li S; Clinical Laboratory, The First Affiliated Hospital of Weifang Medical University (Weifang People's Hospital), Weifang Medical University, Weifang, 261000, Shandong, China. lsr2270@163.com., Duan Y; Clinical Laboratory, The First Affiliated Hospital of Weifang Medical University (Weifang People's Hospital), Weifang Medical University, Weifang, 261000, Shandong, China. yangduan@tmu.edu.cn.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Feb 19; Vol. 150 (2), pp. 97. Date of Electronic Publication: 2024 Feb 19.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/diagnosis , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/diagnosis , Lung Neoplasms*/genetics, Humans ; Early Detection of Cancer ; Carcinogenesis ; Cell Transformation, Neoplastic ; Biomarkers

المؤلفون: Fan X; Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, Jiangsu, China.; Medical School of Nantong University, Nantong University, Nantong, China.; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China., Zhang Q; Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, Jiangsu, China.; Medical School of Nantong University, Nantong University, Nantong, China.; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China., Qin S; Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, Jiangsu, China.; Medical School of Nantong University, Nantong University, Nantong, China.; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China., Ju S; Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, Jiangsu, China. jsq814@hotmail.com.; Department of Laboratory Medicine, Affiliated Hospital of Nantong University, No. 20, Xisi Road, Nantong, 226001, Jiangsu, China. jsq814@hotmail.com.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Feb 08; Vol. 150 (2), pp. 83. Date of Electronic Publication: 2024 Feb 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/diagnosis , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/diagnosis , Lung Neoplasms*/genetics, Humans ; In Situ Hybridization, Fluorescence ; RNA, Circular/genetics ; Biomarkers

المؤلفون: Jiang L; Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Centre, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China., Yang P; Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Centre, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China., Liu Y; Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Centre, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China., Li J; Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Centre, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, China. dr.lijuan@hotmail.com.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Mar 27; Vol. 150 (3), pp. 162. Date of Electronic Publication: 2024 Mar 27.

نوع المنشور: Case Reports; Journal Article; Review

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Imidazoles*, Humans ; Proto-Oncogene Proteins B-raf/genetics ; Oximes/therapeutic use ; Mutation ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Mitogen-Activated Protein Kinase Kinases/genetics ; Mitogen-Activated Protein Kinase Kinases/therapeutic use